The combination therapy can be used as first-line treatment for unresectable or metastatic forms of the cancer.

Unable to secure additional financing amid a stormy market, Tempest Therapeutics has put a call out for partners as it seeks ...

Randomized controlled trials are also needed to determine whether statins can actually reduce the risk for hepatocellular ...

Hepatocellular cancer, the most common form of primary liver cancer, is the fastest rising cause of cancer-related deaths in the United States. Texas has the highest incidence rates of HCC in the ...

For patients with chronic liver disease, statin use is associated with a reduced risk for hepatocellular carcinoma.